Work

Abstract LB272: The ER partial agonist TTC-352 inhibits a novel epithelial-mesenchymal transition pathway, and induces DNA damage in endocrine-resistant breast cancer cells

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-lb272

Authors: Nivida Shete, Debra A. Tonetti

Institution: University of Illinois Chicago

Language: English

Topic: Estrogen and related hormone effects

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409820960

Cites:

Cited by: 1

Related to: 10